{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:48:17Z","timestamp":1792705697661,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1053\/j.gastro.2009.09.021","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T16:47:48Z","timestamp":1253897268000},"page":"671-681.e2","source":"Crossref","is-referenced-by-count":111,"title":["Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection"],"prefix":"10.1053","volume":"138","author":[{"given":"Chihiro","family":"Morishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Shuhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Paschal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun C.","family":"Apodaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek D.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler N.","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas H.","family":"Oberlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Y.\u2013W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2009.09.021_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9505","article-title":"Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome","volume":"20","author":"Alter","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2009.09.021_bib2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2009.09.021_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.09.021_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2009.09.021_bib5","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1572-0241.2002.05993.x","article-title":"Use of complementary and alternative medicine in patients with liver disease","volume":"97","author":"Strader","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.09.021_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.22044","article-title":"Herbal product use by persons enrolled in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial","volume":"47","author":"Seeff","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.021_bib7","first-page":"4457","article-title":"Anticancer potential of silymarin: from bench to bedside","volume":"26","author":"Agarwal","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1053\/j.gastro.2009.09.021_bib8","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1053\/j.gastro.2007.02.038","article-title":"Inhibition of T-cell inflammatory cytokines, hepatocyte NF-\u03baB signaling, and HCV infection by standardized silymarin","volume":"132","author":"Polyak","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.09.021_bib9","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","article-title":"The use of silymarin in the treatment of liver diseases","volume":"61","author":"Saller","year":"2001","journal-title":"Drugs"},{"key":"10.1053\/j.gastro.2009.09.021_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver disease: a systematic review and meta-analysis","volume":"113","author":"Jacobs","year":"2002","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2009.09.021_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/CS20060171","article-title":"Immunopathogenesis in hepatitis C virus cirrhosis","volume":"112","author":"Spengler","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1053\/j.gastro.2009.09.021_bib12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1055\/s-2007-990239","article-title":"Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention","volume":"73","author":"Graf","year":"2007","journal-title":"Planta Med"},{"key":"10.1053\/j.gastro.2009.09.021_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/500952","article-title":"Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C","volume":"193","author":"Morishima","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1053\/j.gastro.2009.09.021_bib14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.510230607","article-title":"The long-term pathological evolution of chronic hepatitis C","volume":"23","author":"Yano","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2009.09.021_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":"Progression of fibrosis in chronic hepatitis C","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2009.09.021_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(03)00239-3","article-title":"Silibinin protects mice from T cell-dependent liver injury","volume":"39","author":"Schumann","year":"2003","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2009.09.021_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jcp.20852","article-title":"Silibinin polarizes Th1\/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells","volume":"210","author":"Lee","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.gastro.2009.09.021_bib18","first-page":"655","article-title":"Pharmacokinetic studies with silymarin in human serum and bile","volume":"6","author":"Lorenz","year":"1984","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1053\/j.gastro.2009.09.021_bib19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1124\/dmd.107.019604","article-title":"The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic fatty liver disease and correlates with plasma caspase-3\/7 activity","volume":"36","author":"Schrieber","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1053\/j.gastro.2009.09.021_bib20","article-title":"Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C","author":"Hawke","year":"2009","journal-title":"J Clin Pharm"},{"key":"10.1053\/j.gastro.2009.09.021_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpba.2007.06.026","article-title":"Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application","volume":"45","author":"Wu","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"10.1053\/j.gastro.2009.09.021_bib22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2008.07.072","article-title":"Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon\/ribavirin therapy","volume":"135","author":"Ferenci","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850901662X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850901662X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T10:27:38Z","timestamp":1544956058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001650850901662X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S001650850901662X"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2009.09.021","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}